Advanced Search
Users Online: 61
Home
About us
Editorial board
Ahead of print
Current issue
Search
Archives
Submit article
Instructions
Subscribe
Contacts
Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
July-September 2020
Volume 5 | Issue 3
Page Nos. 37-42
Online since Wednesday, September 30, 2020
Accessed 6,331 times.
View issue as eBook
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
REVIEWS
Anxiety sensitivity and substance-related disorders: a narrative review
p. 37
Omid Saed, Sahel Khakpoor
DOI
:10.4103/2542-3932.295802
Anxiety sensitivity means fear of anxiety-related sensations which is one of the important factors in the development and maintenance of substance-related disorders. Studies support the underlying, mediating, and moderating role of this construct in the etiology of substancerelated disorders. This review suggests that anxiety sensitivity can play a role in this group of disorders in different ways, such as fear of body sensations, fear of cognitive dyscontrol, and fear of socially observable anxiety symptoms. Finally, high anxiety sensitivity can interfere with the treatment of substance-related disorders as an underlying vulnerability and increase the likelihood of relapse in this group of people.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
LETTER TO THE EDITOR
Is sample size calculation only about numbers?
p. 42
Ranjeeta Kumari, Bhola Nath
DOI
:10.4103/2542-3932.295803
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Next Issue
Previous Issue
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Asia Pacific Journal of Clinical Trials: Nervous System Diseases | Published by Wolters Kluwer -
Medknow
STM Publishing Group Pty Ltd
Online since 16
th
October, 2015